Anti-Staphylococcus aureus single-chain variable region fragments provide protection against mastitis in mice

详细信息    查看全文

• 作者：Man Wang ; Yan Zhang ; Jianguo Zhu
• 关键词：Bovine mastitis ; Staphylococcus aureus ; Single ; chain variable region fragment (scFv) ; Interferon ; gamma ; Interleukin ; 4 ; Tumor necrosis factor ; alpha
• 刊名：Applied Microbiology and Biotechnology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：100
• 期：5
• 页码：2153-2162
• 全文大小：1,559 KB
• 参考文献：Barkema HW, Schukken YH, Zadoks RN (2006) Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 89:1877–1895CrossRef PubMed
  Berger S, Hinz D, Bannantine JP, Griffin JFT (2006) Isolation of high-affinity single-chain antibodies against Mycobacterium avium subsp. paratuberculosis surface proteins from sheep with Johne’s disease. Clin Vaccine Immunol 13:1022–1029PubMedCentral CrossRef PubMed
  Bradley AJ (2002) Bovine mastitis: an evolving disease. Vet J 164:116–128CrossRef PubMed
  Brooks BM, Hart CA, Coleman JW (2005) Differential effects of beta-lactams on human IFN-gamma activity. J Antimicrob Chemother 56:1122–1125CrossRef PubMed
  Brouillette E, Malouin F (2005) The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect 7:560–568CrossRef PubMed
  Chandler RL (1970) Experimental bacterial mastitis in the mouse. J Med Microbiol 3:273–282CrossRef PubMed
  Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK (1998) Pharmacokinetics and biodistribution of genetically-engineered antibodies. Q J Nucl Med 42:225–241PubMed
  Elbers ARW, Miltenburg JD, Lange DDE, Crauwels APP, Barkema HW, Schukken YH (1998) Risk factors for clinical mastitis in a random sample of dairy herds from the southern part of The Netherlands. J Dairy Sci 81:420–426CrossRef PubMed
  Ghahroudi MA, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414:521–526CrossRef
  Guo MY, Zhang NS, Li DP, Liang DJ, Liu ZC, Li FY, Fu YH, Cao YG, Deng XM, Yang ZT (2013) Baicalin plays an anti-inflammatory role through reducing nuclear factor-κB and p38 phosphorylation in S. aureus-induced mastitis. Int Immunopharmacol 16:125–130CrossRef PubMed
  Holt LJ, Enever C, de Wildt RM, Tomlinson IM (2000) The use of recombinant antibodies in proteomics. Curr Opin Biotechnol 11:445–449CrossRef PubMed
  Hoogenboom HR, de Bruine AP, Hufton SE, Hoet RM, Arends JW, Roovers RC (1998) Antibody phage display technology and its applications. Immunotechnol 4:1–20CrossRef
  Hu CM, Gong R, Guo AZ, Chen HC (2010) Protective effect of ligand-binding domain of fibronectin-binding protein on mastitis induced by Staphylococcus aureus in mice. Vaccine 28:4038–4044CrossRef PubMed
  Kato M, Hanyu Y (2013) Construction of an scFv library by enzymatic assembly of VL and VH genes. J Immunol Methods 396:15–22CrossRef PubMed
  Li FQ, Aitken R (2004) Cloning of porcine scFv antibodies by phage display and expression in Escherichia coli. Vet Immunol Immunopathol 97:39–51CrossRef PubMed
  Li Y, Cockburn W, Kilpatrick JB, Whitelam GC (2000) High affinity scFvs from a single rabbit immunized with multiple haptens. Biochem Biophys Res Commun 268:398–404CrossRef PubMed
  Mamo W, Jonsson P, Muller HP (1995) Opsonization of Staphylococcus aureus with a fibronectin-binding protein antiserum induces protection in mice. Microb Pathog 19:49–55CrossRef PubMed
  McCafferty J, Griffiths AD, Winter G, Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nat 348:552–554CrossRef
  Middleton JR (2008) Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines 7:805–815CrossRef PubMed
  Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J (1991) Construction, binding properties, metabolism, and tumor targeting of a single chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 51:6363–6371PubMed
  Pesanti EL, Lorenzo JA (1998) Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis. Clin Orthop 355:290–299CrossRef PubMed
  Saini SS, Farrugia W, Ramsland PA, Kaushik AK (2003) Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings. Int Immunol 15:845–853CrossRef PubMed
  Shinefield HR, Black S (2005) Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev Vaccines 4:669–676CrossRef PubMed
  Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Sci 228:1315–1317CrossRef
  Tan GY, Bai LQ, Zhong JJ (2013) Exogenous 1,4-butyrolactone stimulates A-factor-like cascade and validamycin biosynthesis in Streptomyces hygroscopicus 5008. Biothchnol Bioeng 110:2984–2993CrossRef
  Vincent JL, Sun Q, Dubois MJ (2002) Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 34:1084–1093CrossRef PubMed
  Wang M, Zhang Y, Li BQ, Zhu JG (2015) Construction of scFv that bind both fibronectin-binding protein A and clumping factor A of Stapylococcus aureus. Res in Vet Sci 100:109–114CrossRef
  Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402–3408PubMed
  Zhao YX, Nilsson IM, Tarkowski A (1998) The dual role of interferon-gamma in experimental Staphylococcus aureus septicemia versus arthritis. Immunol 93:80–85CrossRef
  Zhen YH, Jin LJ, Li XY, Guo J, Li Z, Zhang BJ, Fang R, Xu YP (2009) Efficacy of specific egg yolk immunoglobulin (IgY) to bovine mastitis caused by Staphylococcus aureus. Vet Microbiol 133:317–322CrossRef PubMed
  Zwick MB, Wang M, Poignard P, Stienler G, Katinger H, Burton DR, Parren PWHI (2001) Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J Virol 75:12198–12208PubMedCentral CrossRef PubMed
  
• 作者单位：Man Wang (1)
  Yan Zhang (1)
  Jianguo Zhu (1)
  
  1. Shanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai JiaoTong University, 800 Dongchuan Road, Shanghai, 200240, People’s Republic of China
  
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chemistry
  Biotechnology
  Microbiology
  Microbial Genetics and Genomics
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-0614

文摘

Staphylococcus aureus is a leading causative agent of bovine mastitis, which can result in significant economic losses to the dairy industry. However, available vaccines against bovine mastitis do not confer adequate protection, although passive immunization with antibodies may be useful to prevent disease. Hence, we constructed a bovine single-chain variable region fragment (scFv) phage display library using cDNAs from peripheral blood lymphocytes of cows with S. aureus-induced mastitis. After four rounds of selection, eight scFvs that bound S. aureus antigens with high affinity were obtained. The framework regions of the variable domains (VH and VL) of the eight scFvs were highly conserved, and the complementarity-determining regions (CDRs) displayed significant diversity, especially CDR3 of the VH domain. All eight scFvs inhibited S. aureus growth in culture medium. Lactating mice were challenged by injecting S. aureus into the fourth mammary gland. Histopathological analysis showed that treatment with these scFvs prior to bacterial challenge maintained the structure of the mammary acini, decreased infiltration of polymorphonuclear neutrophils, increased levels of interferon-gamma and interleukin-4, and reduced tumor necrosis factor-alpha levels in mammary tissues, as compared with mice treatment with physiological saline (P < 0.05). These novel bovine scFvs may be suitable candidates for therapeutic agents for the prevention of S. aureus-induced bovine mastitis.